Few studies have designed in vitro experiments to elucidate potential mechanism of action showing that the effect of EPC therapy after MI involved IGF and TGFß pathways.116,117 Further studies are needed to better understand how cell therapy could help the right ventricle of PAH patients. The gene discussed is IGF1; the disease is pulmonary arterial hypertension.